Stay updated on Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:36:45.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T06:07:16.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision notes updated to include v3.4.3 and remove v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:29:32.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the site. The prior 3.4.1 notice about government funding and operating status was removed, indicating an update to the page template.
    Difference
    0.4%
    Check dated 2026-02-11T14:13:40.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    A government funding status notice was added to the page. The page revision was updated to v3.4.1, replacing the previous v3.4.0 reference.
    Difference
    0.4%
    Check dated 2026-02-04T10:18:18.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The glossary toggle is now available, and a 'Last Update Submitted that Met QC Criteria' label was added in the updates section along with a 'No FEAR Act Data' notice and a revised page version of 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:00:02.000Z thumbnail image

Stay in the know with updates to Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.